HDAC9 and Huntington disease: Two lines of discovery have placed epigenetics central to neurodegenerative fields: reports of therapeutic benefits associated with histone deacetylase (HDAC)-inhibitor drugs in HD and genetic findings linking neuropathy or cerebellar ataxia-associated adult-onset dementia to deleterious mutations in proteins implicated in regulation of DNA methylation and covalent histone modifications [33].